Allergan will eventually split top jobs, which hedge fund calls 'lame' - STAT

Allergan will eventually split top jobs, which hedge fund calls 'lame' - STAT

More reads

• FDA: Young-blood transfusions provide ‘no proven clinical benefit’ for aging, Alzheimer’s. (STAT)
• Biopharma IPOs pile on in February's brisk first half. (BioWorld)
• Allergan agrees to eventually split top jobs, but big hedge fund calls it a ‘lame’ move. (STAT Plus)